期刊
STATISTICS IN BIOPHARMACEUTICAL RESEARCH
卷 14, 期 1, 页码 33-41出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/19466315.2021.1939774
关键词
Adaptive design; Network model; Response-adaptive randomization
资金
- Department of Health and Social Care
- NIHR [PROD-1017-20006]
- U.K. Medical Research Council [MRC_MC_UU_00002/11, MRC_MC_UU_00002/15]
Clinical trials of a vaccine during an epidemic face particular challenges, and strategies like ring recruitment and novel methods to utilize early infection data can improve power and efficiency of the trial. Additionally, comparing response-adaptive randomization methods can help identify strategies that preserve power and estimation properties while reducing infections.
Clinical trials of a vaccine during an epidemic face particular challenges, such as the pressure to identify an effective vaccine quickly to control the epidemic, and the effect that time-space-varying infection incidence has on the power of a trial. We illustrate how the operating characteristics of different trial design elements may be evaluated using a network epidemic and trial simulation model, based on COVID-19 and individually randomized two-arm trials with a binary outcome. We show that ring recruitment strategies, prioritizing participants at an imminent risk of infection, can result in substantial improvement in terms of power in the model we present. In addition, we introduce a novel method to make more efficient use of the data from the earliest cases of infection observed in the trial, whose infection may have been too early to be vaccine-preventable. Finally, we compare several methods of response-adaptive randomization (RAR), discussing their advantages and disadvantages in the context of our model and identifying particular adaptation strategies that preserve power and estimation properties, while slightly reducing the number of infections, given an effective vaccine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据